REPORTS

Let’s Pullulate and Expand Your Business

Autologous Stem Cell Based Therapies Market - Global Professional Analysis and Forecast to 2026

Oct 27, 2019  |  208 PAGES  |  REPORT CODE: CMM225872
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Autologous Stem Cell Based Therapies market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 6.4% during the forecast period.

This report presents the market size and development trends by detailing the Autologous Stem Cell Based Therapies market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Autologous Stem Cell Based Therapies market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Autologous Stem Cell Based Therapies industry and will help you to build a panoramic view of the industrial development.

Autologous Stem Cell Based Therapies Market, By Type:

  • Embryonic Stem Cell

  • Resident Cardiac Stem Cells

  • Umbilical Cord Blood Stem Cells

Autologous Stem Cell Based Therapies Market, By Application:

  • Neurodegenerative Disorders

  • Autoimmune Diseases

  • Cardiovascular Diseases

Some of the leading players are as follows:

  • Anterogen

  • AbbVie

  • Astellas Pharma

  • Valeant

  • Athersys

  • AM-Pharma

  • Brainstorm Cell Therapeutics

  • Osiris Therapeutics

  • American CryoStem

  • Beike Biotechnology

  • Vericel Corporation

  • Holostem Advanced Therapies

  • Baxter International

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Autologous Stem Cell Based Therapies Market: Technology Type Analysis

  • 4.1 Autologous Stem Cell Based Therapies Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Autologous Stem Cell Based Therapies Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Embryonic Stem Cell

    • 4.3.2 Resident Cardiac Stem Cells

    • 4.3.3 Umbilical Cord Blood Stem Cells

5 Autologous Stem Cell Based Therapies Market: Product Analysis

  • 5.1 Autologous Stem Cell Based Therapies Product Market Share Analysis, 2018 & 2026

  • 5.2 Autologous Stem Cell Based Therapies Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Autologous Stem Cell Based Therapies Market: Application Analysis

  • 6.1 Autologous Stem Cell Based Therapies Application Market Share Analysis, 2018 & 2026

  • 6.2 Autologous Stem Cell Based Therapies Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Neurodegenerative Disorders

    • 6.3.2 Autoimmune Diseases

    • 6.3.3 Cardiovascular Diseases

7 Autologous Stem Cell Based Therapies Market: Regional Analysis

  • 7.1 Autologous Stem Cell Based Therapies Regional Market Share Analysis, 2018 & 2026

  • 7.2 Autologous Stem Cell Based Therapies Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Anterogen

    • 9.1.1 Anterogen Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 AbbVie

    • 9.2.1 AbbVie Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Astellas Pharma

    • 9.3.1 Astellas Pharma Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Valeant

    • 9.4.1 Valeant Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Athersys

    • 9.5.1 Athersys Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 AM-Pharma

    • 9.6.1 AM-Pharma Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Brainstorm Cell Therapeutics

    • 9.7.1 Brainstorm Cell Therapeutics Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Osiris Therapeutics

    • 9.8.1 Osiris Therapeutics Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 American CryoStem

    • 9.9.1 American CryoStem Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Beike Biotechnology

    • 9.10.1 Beike Biotechnology Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 Vericel Corporation

    • 9.11.1 Vericel Corporation Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 Holostem Advanced Therapies

    • 9.12.1 Holostem Advanced Therapies Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

  • 9.13 Baxter International

    • 9.13.1 Baxter International Company overview

    • 9.13.2 Financial performance

    • 9.13.3 Product benchmarking

    • 9.13.4 Strategic initiatives

    • 9.13.5 SWOT analysis

 

The List of Tables and Figures (Totals 67 Figures and 153 Tables)

  • Figure Embryonic Stem Cell Autologous Stem Cell Based Therapies market, 2015 - 2026 (USD Million)

  • Figure Resident Cardiac Stem Cells Autologous Stem Cell Based Therapies market, 2015 - 2026 (USD Million)

  • Figure Umbilical Cord Blood Stem Cells Autologous Stem Cell Based Therapies market, 2015 - 2026 (USD Million)

  • Figure Neurodegenerative Disorders market, 2015 - 2026 (USD Million)

  • Figure Autoimmune Diseases market, 2015 - 2026 (USD Million)

  • Figure Cardiovascular Diseases market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Autologous Stem Cell Based Therapies market, by country, 2015 - 2026 (USD Million)

  • Table North America Autologous Stem Cell Based Therapies market, by type, 2015 - 2026 (USD Million)

  • Table North America Autologous Stem Cell Based Therapies market, by product, 2015 - 2026 (USD Million)

  • Table North America Autologous Stem Cell Based Therapies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Autologous Stem Cell Based Therapies market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Autologous Stem Cell Based Therapies market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Autologous Stem Cell Based Therapies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Autologous Stem Cell Based Therapies market, by type, 2015 - 2026 (USD Million)

  • Table Canada Autologous Stem Cell Based Therapies market, by product, 2015 - 2026 (USD Million)

  • Table Canada Autologous Stem Cell Based Therapies market, by application, 2015 - 2026 (USD Million)

  • Table Europe Autologous Stem Cell Based Therapies market, by country, 2015 - 2026 (USD Million)

  • Table Europe Autologous Stem Cell Based Therapies market, by type, 2015 - 2026 (USD Million)

  • Table Europe Autologous Stem Cell Based Therapies market, by product, 2015 - 2026 (USD Million)

  • Table Europe Autologous Stem Cell Based Therapies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Autologous Stem Cell Based Therapies market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Autologous Stem Cell Based Therapies market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Autologous Stem Cell Based Therapies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Autologous Stem Cell Based Therapies market, by type, 2015 - 2026 (USD Million)

  • Table Germany Autologous Stem Cell Based Therapies market, by product, 2015 - 2026 (USD Million)

  • Table Germany Autologous Stem Cell Based Therapies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Autologous Stem Cell Based Therapies market, by type, 2015 - 2026 (USD Million)

  • Table France Autologous Stem Cell Based Therapies market, by product, 2015 - 2026 (USD Million)

  • Table France Autologous Stem Cell Based Therapies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Autologous Stem Cell Based Therapies market, by type, 2015 - 2026 (USD Million)

  • Table Italy Autologous Stem Cell Based Therapies market, by product, 2015 - 2026 (USD Million)

  • Table Italy Autologous Stem Cell Based Therapies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Autologous Stem Cell Based Therapies market, by type, 2015 - 2026 (USD Million)

  • Table Spain Autologous Stem Cell Based Therapies market, by product, 2015 - 2026 (USD Million)

  • Table Spain Autologous Stem Cell Based Therapies market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Autologous Stem Cell Based Therapies market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Autologous Stem Cell Based Therapies market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Autologous Stem Cell Based Therapies market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Autologous Stem Cell Based Therapies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Autologous Stem Cell Based Therapies market, by type, 2015 - 2026 (USD Million)

  • Table China Autologous Stem Cell Based Therapies market, by product, 2015 - 2026 (USD Million)

  • Table China Autologous Stem Cell Based Therapies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Autologous Stem Cell Based Therapies market, by type, 2015 - 2026 (USD Million)

  • Table Japan Autologous Stem Cell Based Therapies market, by product, 2015 - 2026 (USD Million)

  • Table Japan Autologous Stem Cell Based Therapies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Autologous Stem Cell Based Therapies market, by type, 2015 - 2026 (USD Million)

  • Table India Autologous Stem Cell Based Therapies market, by product, 2015 - 2026 (USD Million)

  • Table India Autologous Stem Cell Based Therapies market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Autologous Stem Cell Based Therapies market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Autologous Stem Cell Based Therapies market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Autologous Stem Cell Based Therapies market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Autologous Stem Cell Based Therapies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Autologous Stem Cell Based Therapies market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Autologous Stem Cell Based Therapies market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Autologous Stem Cell Based Therapies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Autologous Stem Cell Based Therapies market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Autologous Stem Cell Based Therapies market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Autologous Stem Cell Based Therapies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Autologous Stem Cell Based Therapies market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Autologous Stem Cell Based Therapies market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Autologous Stem Cell Based Therapies market, by application, 2015 - 2026 (USD Million)

  • Table MEA Autologous Stem Cell Based Therapies market, by country, 2015 - 2026 (USD Million)

  • Table MEA Autologous Stem Cell Based Therapies market, by type, 2015 - 2026 (USD Million)

  • Table MEA Autologous Stem Cell Based Therapies market, by product, 2015 - 2026 (USD Million)

  • Table MEA Autologous Stem Cell Based Therapies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Autologous Stem Cell Based Therapies market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Autologous Stem Cell Based Therapies market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Autologous Stem Cell Based Therapies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Autologous Stem Cell Based Therapies market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Autologous Stem Cell Based Therapies market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Autologous Stem Cell Based Therapies market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Anterogen Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table AbbVie Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Astellas Pharma Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Valeant Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Athersys Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table AM-Pharma Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Brainstorm Cell Therapeutics Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Osiris Therapeutics Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table American CryoStem Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Beike Biotechnology Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Vericel Corporation Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Holostem Advanced Therapies Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Baxter International Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top